Chronic Obstructive Pulmonary Disease News and Research

Latest Chronic Obstructive Pulmonary Disease News and Research

Selenium and vitamin E supplements do not prevent prostate cancer

Initial, independent review of study data from the Selenium and Vitamin E Cancer Prevention Trial (SELECT), funded by the National Cancer Institute (NCI) and other institutes that comprise the National Institutes of Health shows that selenium and vitamin E supplements, taken either alone or together, did not prevent prostate cancer.

28 Oct 2008

Respiratory syncytial virus may hide in the lungs, lead to asthma

Conventional wisdom has been that respiratory syncytial virus (RSV) - a common virus that causes infection in the lungs - comes and goes in children without any long lasting impact.

27 Oct 2008

Human rhinovirus found to manipulate genes

Sneezing, runny nose and chills? You might blame the human rhinovirus (HRV), which causes 30 to 50 percent of common colds. But in reality, it's not the virus itself but HRV's ability to manipulate your genes that is the true cause of some of the most annoying cold symptoms.

26 Oct 2008

Preventing lung disease in indigenous communities

A pilot health initiative partly developed at the University of Sydney could significantly reduce the debilitating impact of chronic lung disease within indigenous communities.

13 Oct 2008

Red wine cuts smokers risk for lung cancer

Cancer experts say drinking red wine may decrease the risk of lung cancer in men who smoke, because of its antioxidant properties.

7 Oct 2008

Popular COPD treatment increases risk for cardiac events, cardiac death

New research out of Wake Forest University School of Medicine shows that use of the most commonly prescribed once-a-day treatment for chronic obstructive pulmonary disease (COPD) for longer than one month increases the risk of cardiovascular death, heart attack or stroke by more than 50 percent

24 Sep 2008

Key component of chronic obstructive pulmonary disease identified

For the first time, researchers have demonstrated a close correlation between the decline in a key component of the lung's antioxidant defense system and the progression of chronic obstructive pulmonary disease (COPD) in humans.

14 Sep 2008

Risk assessment tool finds that blacks with breathing conditions have higher risk for developing lung cancer than whites

Blacks with chronic obstructive pulmonary disease -- including chronic bronchitis and some types of serious chronic asthma -- have a risk for developing lung cancer about twice as high as that of whites with the condition, according to a study published in the journal Cancer Prevention Research, Reuters reports.

10 Sep 2008

Pharmacists reduce hospital visits for patients with chronic obstructive pulmonary disease

Patients with chronic obstructive pulmonary disease (COPD) experience 55% fewer hospital admissions and 50% less visits to accident and emergency departments when clinical pharmacists intervene in their care, research launched at the British Pharmaceutical Conference (BPC) in Manchester has shown.

8 Sep 2008

MorphoSys announces publication of first MOR103 data

MorphoSys AG announced today the publication of a first data package for its most advanced proprietary drug development program MOR103, a fully human HuCAL antibody directed against GM-CSF, in the journal "Molecular Immunology".

2 Sep 2008

New beta-blocker for heart disease and angina

Researchers at The University of Nottingham have been awarded £2.8 million by the Wellcome Trust to develop a new drug that could ease the suffering of hundreds of thousands of heart disease patients who are unable to take beta-blockers.

28 Aug 2008

NicOx updates on PF-03187207 and research collaboration with Pfizer

NicOx S.A. has announced the results of a dose-ranging phase 2 study conducted with PF‑03187207 in Japanese patients with glaucoma by its partner Pfizer Inc. PF-03187207 is a nitric oxide-donating prostaglandin analog. The study was designed to compare the safety and efficacy of several doses of PF-03187207 to Xalatan (latanoprost) and enrolled 112 Japanese patients with primary open-angle glaucoma or ocular hypertension.

25 Aug 2008

Scientists engineer first drug-delivery particles capable of passing through human mucus

Chemical engineers from Johns Hopkins University have broken the "mucus barrier," engineering the first drug-delivery particles capable of passing through human mucus - regarded by many as nearly impenetrable - and carrying medication that could treat a range of diseases. Those conditions include lung cancer, cervical cancer and cystic fibrosis, the research noted in a presentation scheduled for the 236th National Meeting of the American Chemical Society.

20 Aug 2008

New drug targets main culprit in common colds

The Melbourne drug company Biota has announced trials of a drug to treat the human rhinovirus (HRV) which is the main culprit in the common cold.

12 Aug 2008

GSK begins shipments of Fluarix and FluLaval to U.S. customers for 2008-2009 flu season

GlaxoSmithKline has announced that it will begin shipment of Flulaval [Influenza Virus Vaccine] and Fluarix [Influenza Virus Vaccine] to U.S. customers for the 2008-2009 influenza season.

11 Aug 2008

Premature babies at risk of lung problems later on

According to Australian researchers some premature babies may have a higher risk of developing emphysema and other lung problems later on.

29 Jul 2008

60% of people in the U.S. age 18 and older have at least one chronic medical condition

About six of every 10 people in the United States age 18 and older have at least one chronic medical condition, according to the latest News and Numbers from the Agency for Healthcare Research ands Quality.

3 Jun 2008

CFC-propelled inhalers no longer available as of Dec. 31 2008

The U.S. Food and Drug Administration today issued a public health advisory to alert patients, caregivers and health care professionals to switch to hydrofluoroalkane (HFA)-propelled albuterol inhalers because chlorofluorocarbon (CFC)-propelled inhalers will not be available in the United States after Dec. 31, 2008.

30 May 2008

Patients to benefit from multi-million pound research funding

NHS patients in North West London will benefit from a multi-million pound research project leading to the rapid introduction of new, effective treatments for a wide range of medical conditions.

27 May 2008

Common gene disorder doubles risk of lung cancer, even among nonsmokers

Mayo Clinic researchers have found that carrying a common genetic disorder doubles the risk of developing lung cancer in smokers and nonsmokers.

26 May 2008

Chronic Obstructive Pulmonary Disease News and Research

Latest Chronic Obstructive Pulmonary Disease News and Research

Selenium and vitamin E supplements do not prevent prostate cancer

Respiratory syncytial virus may hide in the lungs, lead to asthma

Human rhinovirus found to manipulate genes

Preventing lung disease in indigenous communities

Red wine cuts smokers risk for lung cancer

Popular COPD treatment increases risk for cardiac events, cardiac death

Key component of chronic obstructive pulmonary disease identified

Risk assessment tool finds that blacks with breathing conditions have higher risk for developing lung cancer than whites

Pharmacists reduce hospital visits for patients with chronic obstructive pulmonary disease

MorphoSys announces publication of first MOR103 data

New beta-blocker for heart disease and angina

NicOx updates on PF-03187207 and research collaboration with Pfizer

Scientists engineer first drug-delivery particles capable of passing through human mucus

New drug targets main culprit in common colds

GSK begins shipments of Fluarix and FluLaval to U.S. customers for 2008-2009 flu season

Premature babies at risk of lung problems later on

60% of people in the U.S. age 18 and older have at least one chronic medical condition

CFC-propelled inhalers no longer available as of Dec. 31 2008

Patients to benefit from multi-million pound research funding

Common gene disorder doubles risk of lung cancer, even among nonsmokers

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Chronic Obstructive Pulmonary Disease News and Research

Latest Chronic Obstructive Pulmonary Disease News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in